Abstract
Myasthenia gravis is one of the best characterized human autoimmune disorders1–4. Circulating autoantibodies to the nicotinic acetylcholine receptor (AChR) at the neuromuscular junction play a prominent part in the effector phase of the disease5,6, but little is known about the induction phase, that is, the immunoregulation. Indirect evidence, such as thymic abnormalities7 and the association with certain histocompatibility antigens (for example HLA-B8,-DR38,9) suggests a defect of immunoregulation at the level of thymus-dependent (T) lymphocytes. We report here on the isolation of autoreactive T cells from six patients with myasthenia gravis. From one of these patients, who is homozygous for HLA-DR3, we established a long-term T-cell line. The line cells are specific for purified fish and human AChR, display the surface phenotype of inducer/helper T cells and are genetically restricted to HLA-DR3. AChR-induced proliferation could be inhibited with two monoclonal antibodies against monomorphic DR determinants and also with DR3-specific alloantiserum.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lennon, V. A. Hum. Path. 9, 541–551 (1978).
Lindstrom, J. M. Adv. Immun. 27, 1–50 (1979).
Vincent, A. Physiol. Rev. 60, 756–823 (1980).
Drachman, D. B. A. Rev. Neurosci. 4, 195–225 (1981).
Toyka, K. V., Drachman, D. B., Pestronk, A. & Kao, I. Science 190, 397–399 (1975).
Lindstrom, J. M., Engel, A. G., Seybold, M. E., Lennon, V. A. & Lambert, E. H. J. exp. Med. 144, 739–753 (1976).
Castleman, B. Ann. N.Y. Acad. Sci. 135, 496–503 (1966).
Compston, D. A. S., Vincent, A., Newsom-Davis, J. & Batchelor, J. R. Brain 103, 579–601 (1980).
Grosse-Wilde, H. et al. Dt. med. Wschr. 108, 694–700 (1983).
Abramsky, O., Aharonov, A., Webb, C. & Fuchs, S. Clin. exp. Immun. 19, 11–16 (1975).
Richman, D., Patrick, J. & Arnason, B. G. W. New Engl. J. Med. 294, 694–698 (1976).
Conti-Tronconi, B., Morgutti, M., Sghirlanzoni, A. & Clementi, F. Neurology 29, 496–501 (1979).
McQuillen, D. P., Koethe, S. M. & McQuillen, M. P. J. Neuroimmun. 5, 59–65 (1983).
Paul, W. E., Sredni, B. & Schwartz, R. H. Nature 294, 697–699 (1981).
Reinherz, E. L. & Schlossman, S. F. New Engl. J. Med. 303, 370–373 (1980).
Guy, K., Van Heyningen, V., Cohen, B. B., Deane, D. L. & Steel, C. M. Eur. J. Immun. 12, 942–948 (1982).
Johnson, J. P., Meo, T., Riethmüller, G., Schendel, D. J. & Wank, R. J. exp. Med. 156, 104–111 (1982).
Newsom-Davis, J., Willcox, N. & Calder, L. New Engl. J. Med. 305, 1313–1318 (1981).
Lindstrom, J. M., Seybold, M. E., Lennon, V. A., Whittingham, S. & Duane, D. D. Neurology 26, 1054–1059 (1976).
Toyka, K. V. et al. Klin. Wschr. 57, 937–942 (1979).
Clarke, C., Vincent, A. & Newson-Davis, J. J. clin. Sci. 56, 1 Abstr. (1979).
Hohlfeld, R., Kalies, I., Heinz, F., Kalden, J. R. & Wekerle, H. J. Immun. 126, 1355–1359 (1981).
Hohlfeld, R., Kalies, I., Ernst, M., Ketelsen, U. P. & Wekerle, H. J. neurol. Sci. 57, 265–280 (1982).
Wekerle, H., Hohlfeld, R., Ketelsen, U. P., Kalden, J. R. & Kalies, I. Ann. N.Y. Acad. Sci. 377, 455–476 (1981).
Ryder, L. P., Anderson, E. & Svejgaard, A. HLA and Disease Registry 3rd edn (Munksgaard, Copenhagen, 1979).
Kalies, I., Kalden, J. R., Heinz, F., Janzen, R. W. C. & Lachenmayer, L. Klin. Wschr. 57, 875–881 (1979).
Kurnick, J. T. et al. Scand. J. Immun. 10, 563–573 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hohlfeld, R., Toyka, K., Heininger, K. et al. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 310, 244–246 (1984). https://doi.org/10.1038/310244a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/310244a0
This article is cited by
-
Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis
Neurological Sciences (2014)
-
Unravelling the pathogenesis of myasthenia gravis
Nature Reviews Immunology (2002)
-
Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on α3 type IV collagen
Kidney International (1996)
-
Overexpression of Select T Cell Receptor Vβ Gene Families within CD4+ and CD8+ T Cell Subsets of Myasthenia Gravis Patients: A Role for Superantigen(s)?
Molecular Medicine (1996)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.